Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601.

BD²: Breakthrough Discoveries for thriving with Bipolar Disorder today announced the first public release of data from the BD² Integrated Network Longitudinal Cohort Study (LCS).

Scientists led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and collaborators have identified genetic pathways and compounds capable of protecting cone photoreceptors from the…

Some people have a greater genetic risk than others of developing type 2 diabetes. Now, more of these at-risk people are actually developing diabetes than previously.

Researchers have developed a rapid direct-from-urine test that identifies which first-line antibiotic is likely to work for a urinary tract infection in an average of 5.85 hours, instead of the…

Researchers led by the Fisabio Foundation found that dermcidin, a natural antimicrobial peptide present in sweat and respiratory tissues, can block influenza infection by binding to a highly conserved region…

A randomized placebo-controlled trial found that fluvoxamine, a low-cost antidepressant, reduced fatigue and improved quality of life in adults with long COVID, offering one of the first evidence-based medication options…

Researchers found that people with atrial fibrillation had lower MRI-based glymphatic activity and poorer cognitive performance than healthy controls, with the greatest impairment seen in non-paroxysmal AF. In patients who…

Deep sleep does far more than rest the body — it activates a powerful brain-driven system that controls growth hormone, fueling muscle and bone strength, metabolism, and even mental performance.…

Why do stressful moments so often push people toward habits like drinking? A new study from Texas A&M University offers one of the clearest answers yet, identifying a direct connection…